Involvement of Fc Receptors in Disorders of the Central Nervous System
- 21 October 2009
- journal article
- review article
- Published by Springer Nature in NeuroMolecular Medicine
- Vol. 12 (2) , 164-178
Abstract
Immunoglobulins are proteins with a highly variable antigen-binding domain and a constant region (Fc domain) that binds to a cell surface receptor (FcR). Activation of FcRs in immune cells (lymphocytes, macrophages, and mast cells) triggers effector responses including cytokine production, phagocytosis, and degranulation. In addition to their roles in normal responses to infection or tissue injury, and in immune-related diseases, FcRs are increasingly recognized for their involvement in neurological disorders. One or more FcRs are expressed in microglia, astrocytes, oligodendrocytes, and neurons. Aberrant activation of FcRs in such neural cells may contribute to the pathogenesis of major neurodegenerative conditions including Alzheimer’s disease, Parkinson’s disease, ischemic stroke, and multiple sclerosis. On the other hand, FcRs may play beneficial roles in counteracting pathological processes; for e.g., FcRs may facilitate removal of amyloid peptides from the brain and so protect against Alzheimer’s disease. Knowledge of the functions of FcRs in the nervous system in health and disease is leading to novel preventative and therapeutic strategies for stroke, Alzheimer’s disease, and other neurological disorders.Keywords
This publication has 166 references indexed in Scilit:
- Cross-regulation of signaling by ITAM-associated receptorsNature Immunology, 2009
- Toll-like receptors in neurodegenerationBrain Research Reviews, 2009
- Neuroprotection in stroke by complement inhibition and immunoglobulin therapyNeuroscience, 2009
- Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidaseProceedings of the National Academy of Sciences, 2008
- Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenalExperimental Neurology, 2008
- Chapter 3 New Insights on Mast Cell Activation via the High Affinity Receptor for IgE2008
- Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell deathProceedings of the National Academy of Sciences, 2007
- Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficitsProceedings of the National Academy of Sciences, 2007
- Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptorsProceedings of the National Academy of Sciences, 2006
- Pathways towards and away from Alzheimer's diseaseNature, 2004